Related by context. All words. (Click for frequent words.) 60 Rockwood Holdings NYSE 57 Renewable Obligation Certificate 55 Renewables Obligation Certificate 55 ROC 55 Raleigh Orthopaedic Clinic 51 Human Hookworm Vaccine Initiative 50 IRAD 50 Biotechnology DCB 50 EchoCRT 50 RenalGuard System TM 50 DF HCC 49 National Oncologic PET 49 CALGB 49 DEcIDE 49 NSABP 49 retrospective cohort study 49 prospective nonrandomized 48 BCIRG 48 VITAL Trial 48 laparoscopic radical nephrectomy 48 longitudinal cohort study 48 Interreg III 48 TaiGen 47 Rockwood Holdings Inc 47 CSPG 47 NCIC CTG 47 ATOLL 47 Intervention Trial GAIT 47 MDACC 47 Cohort Consortium 47 Thorough QT TQT 47 BioNumerik 47 prospective randomized multicenter 47 multicentre prospective 47 Aortic Dissection 47 Anceta 47 OLYMPIA registry 47 HORIZONS AMI trial 46 lymphoblastoid cell lines 46 FORMOSAT 46 USSOUTHCOM 46 ICDF 46 papillary renal cell carcinoma 46 Randomized Evaluation 46 placebo controlled Phase III 46 CHAMPION PCI 46 Patient Registry 46 National Biosurveillance Integration 46 REALITY Trial 46 Country Coordinating Mechanism 46 LUMINATE 46 Public Access Defibrillation 46 PACF 46 Truvada tablets 46 Val HeFT 46 PRESEPT 46 ONTARGET 46 International HapMap Consortium 46 HPTN 46 prospective multicenter 46 Sunnylife Global 46 Stenting Trial CREST 46 TECNALIA 46 DP b# 46 GPNMB expression 46 International HapMap Project 45 OncoTherapy Science 45 prospective observational 45 ELCAP 45 EORTC 45 Registry NOPR 45 haplotype map 45 fosbretabulin 45 Initiative SFI 45 TrialNet 45 NICE SUGAR 45 Bowel Project NSABP 45 EDIN 45 BROADEN 45 Sunnylife 45 ADDAX 45 Fund ICDF 45 ACS NSQIP 45 prospective multicentre 45 controlled multicenter 45 observational cohort 45 Renal Cell Carcinoma RCC 45 Fracture Intervention Trial 45 Interagency Coordinating Committee 45 CAGI 45 Dr. Kandzari 45 PRTMI 45 Peopleas Republic 45 RE LY ® 45 Radiation Therapy Oncology 45 CytoPharm 45 Optivia Biotechnology 45 ADHERE 45 Esso Angola 45 CIPI 44 chromosome #p# [002] 44 Pharm Olam International 44 Accelovance 44 REGARDS 44 Relief Tzu Chi 44 ISOCOUNTRY3 44 INRS 44 Group RTOG 44 NSDI 44 Phase III psoriasis 44 DotAsia Organisation 44 SWOG 44 EDEMA3 44 relapsing multiple sclerosis 44 Ovarian Cancer Screening 44 PARTNER Trial 44 DIPECHO 44 HICS 44 Domestic Preparedness Consortium 44 Carotid Revascularization Endarterectomy vs. 44 pharmacodynamic PD 44 HeFT 44 SEER database 44 ESHO 44 COGENT 44 CONDOR 44 prospective observational cohort 44 Myocardial Infarction 44 Formosat 2 44 ACRIN 44 retrospective cohort 44 Suspicious Activity Reporting 44 Covalys 44 VerifyNow P#Y# 44 NSABP B 44 TEC #OL 44 REVIVE Diabetes 44 NCCTG 44 MSMF 44 Pharm Olam 44 p# biomarker 44 biosimulation 44 ICAEL 44 Enterprise WOFE 44 ExTRACT TIMI 44 BARI 2D 43 Maryland eCare 43 SERVIR 43 Normative Aging Study 43 prelicensure 43 Dialysis Outcomes 43 SK Chen ChipMOS 43 NSQIP 43 WTCCC 43 Clinical Lipidology 43 Montreal Sentry Select 43 Multi Disciplinary Team 43 MultiService Forum 43 Cathay Fin 43 CDEMA 43 multicenter trials 43 Khaan Quest 43 Syllego system 43 Affymetrix microarray technology 43 WHO TDR 43 STSP 43 NCCTG N# 43 Primera Bioscience 43 USAID DART 43 ENDEAVOR clinical 43 UNU MERIT 43 TTY Biopharm 43 Serious Adverse Event 43 Perinatal Mortality 43 PRECiSE 43 RFCA 43 MTCP 43 HSCR 43 genomewide association study 43 atherothrombotic disease 43 IPAH 43 clinical pharmacology studies 43 ZACTIMA 43 MCID 43 ILLUSTRATE 43 Tzu Chi Buddhist 43 PCWP 43 linear regression analyzes 43 PTI MIJ 43 Ovarian PLCO Cancer 43 Surviving Sepsis Campaign 43 AIDS Clinical Trials 43 SPEAR 43 Asvaco 43 observational cohort study 43 Aegera Therapeutics Inc. 43 Gintech Energy Corporation 43 multicentric 43 Stenting Trial 43 EuroSCORE 43 MEND CABG 43 APEX AMI trial 43 Thrombolysis 43 TTNews 43 BUMED 43 Tibotec BVBA 43 Heart Failure Trial 43 Lifeline Vascular Access 43 CareManager 43 MIVI TRUST 43 miRview mets 43 retrospectively analyzed 43 ASSERT 43 TORR TM 43 Alpha Tocopherol Beta Carotene 42 EBMT criteria 42 Rx Response 42 placebo controlled clinical 42 FDG PET CT 42 TaiGen Biotechnology 42 REMINYL ® 42 NLnet Labs 42 asubsidiary 42 ROCKWELL AUTOMATION 42 Alzheimer Disease Genetics 42 preclinical efficacy 42 Renewables Obligation Certificates 42 iChem ® VELOCITY 42 Interagency Registry 42 CaPSURE 42 INTERHEART study 42 Kuhnil 42 cortical stimulation 42 Cohort Study 42 BioAxone 42 YONDELIS 42 Megamas Training Company 42 JASPERS 42 PacificNet iMobile 42 RFID USN 42 Incident Command System 42 GVAX Pancreas 42 Medical System NDMS 42 ENGAGE AF TIMI 42 Index SPI SPIEX 42 Acute Decompensated Heart Failure 42 Digital Mammographic Imaging 42 BTCO 42 Carticept 42 Katangan Copperbelt 42 prospective observational studies 42 Kahalalide F 42 prospective randomized controlled 42 childhood acute lymphoblastic 42 acadesine 42 Asthma Intervention 42 Guangzhou Hangzhou 42 hemangioblast 42 Needs Assessments 42 SAREX 42 Declares Dividend Quick Facts 42 KRAS variant 42 OTCBB MNLU 42 S Aktiengesellschaft FSE 42 NSRS 42 KHIDI 42 RADARSAT 2 42 pain palliation 42 Biomodels 42 Medifacts 42 DEVELOPMENT GROUP 42 Solidarités 42 ImmuKnow R 42 Congressionally funded 42 MagEnergy 42 Sentinel Lymph Node 42 TandemHeart System 42 Multiethnic Cohort 42 GEOCommand 42 FDG-PET/CT 42 multicentre randomized 42 TAXUS V 42 Adama Guindo 42 ASNR 42 Extended Continental Shelf 42 variant rs# 42 OOTC TSXV 42 TAXUS ARRIVE 42 AMPATH 42 Oranjewoud NV 42 CEEA 42 UNICEF UNFPA 42 Enzyme Replacement Therapy 42 prospectively randomized 42 MAXIMA 42 FirstGateways 42 TOCCATA 42 recurrent glioblastoma multiforme 42 Escort Instruments 42 Centripetal Dynamics Inc. 42 differential gene expression 42 Sequence Database 42 HKSTP 42 FDG PET imaging 42 Cancer Genetic Markers 42 efficacy evaluable 41 Phase IIb clinical trials 41 Mingyuan Medicare Development 41 randomized discontinuation 41 MOU establishes 41 ACC NCDR 41 Critical Care Transport 41 Lymph node 41 MobiCom 41 darunavir r 41 Amphibian Monitoring Program 41 GEECF 41 NCHC 41 SF #v# 41 MCAN 41 Contrast Echocardiography 41 enroller 41 NSPO 41 EUS FNA 41 Adult Cardiac Surgery 41 NPM 41 Multicenter 41 # #-# [006] 41 Loramyc ™ 41 ECASS 41 HIVNET 41 TECHNOLOGIES Bermuda LTD 41 CTIC 41 USTDA grant 41 ACCELERATE 41 Haixi 41 RECIST Response Evaluation Criteria 41 TRA 2P 41 Signs Framework Agreement 41 PLCO 41 BCSP 41 FEO 41 USAISR 41 Swedish Mammography Cohort 41 Shanghai ChemPartner 41 UNDAF 41 ABSSSI 41 ALS MND 41 Programme MTCP 41 HGU 41 clinico pathological 41 NS# [004] 41 Thoracic Stent Graft 41 SoftScan ® 41 AC Plastiques 41 PhG alpha 1 41 TEAM DRF 41 PIA XI top 41 CSHA 41 IJIS 41 Rate ORR 41 Sichuan Earthquake Relief 41 HATC 41 Prospective Multicenter 41 Lp PLA 2 41 CETC 41 DPETAP 41 CARDI 41 Xietongmen Project 41 BSIs 41 CoPs 41 jsessionid = 41 rhMBL 41 myoblast 41 Kaplan Meier analysis 41 MERT 41 MOVING AVERAGE CROSSOVER ALERT 41 OFFICE ADDRESS 41 dbGaP 41 Myocardial Infarction TIMI Study 41 Immunitor 41 TRILOGY ACS 41 Dubbo Zirconia Project 41 BioImage Study 41 PEMSEA 41 ACOMPLIA R 41 TAGS PGOV 41 clinically evaluable 41 Decompensated Heart Failure 41 WHAT ABOUT YOUR 41 Cooperation Framework 41 n4a 41 Director Douglas Paal 41 Pro Spect Or 41 inTaiwan 41 CGWIC 41 Lung Injury 41 CCEVS 41 LWF DWS 41 Child Neurology 41 Disaster Response Teams 41 Limited Lightscape Technologies 41 PD2i ® 41 CBOSS 41 HIV AIDS BC CfE 41 Exelixis XL# 41 Appendix VII 41 pharmacokinetic PK 41 NewMarket Greenfield Partners 41 Intervention Trial 41 CardioFit 41 REACH Registry 41 BIOMED 41 TRIAS 41 ATTAIN 41 NCI Surveillance Epidemiology 41 Tosoh Corporation 41 ABSORB trial 41 Viralytics 41 AGER 41 Ziqiang 41 PSDS 41 CHARISMA trial 41 RTOG 41 Hsin Chu 41 ImmuKnow assay 41 BioMarck 41 backgrounder PDF 41 ACZ# 41 HNF 41 Drug Coated Coronary 41 PIA CAR Kalinga 41 Mmamabula Energy Complex 41 APTT 41 Thorough QT 41 AIR2 41 Sigma Tau Pharmaceuticals 41 Vascular Disease Foundation 41 NLTX 41 Fireman Fund Heritage 40 QTinno 40 Baltimore Longitudinal Study 40 Watson LIMS 40 serum leptin 40 COPERNICUS 40 MTWA testing 40 Nanotechnology Characterization Laboratory 40 Tandem Labs 40 clinicopathological 40 PKC# 40 NPSF 40 HZW 40 Agrarian Reform Communities 40 Integrand 40 immunohistochemical analysis 40 OvaRex MAb 40 Women Ischemia Syndrome 40 CLARITY TIMI 40 GSM UMTS CDMA 40 MIMOS Bhd 40 iCardiac 40 Technology BCIT 40 UroVysion 40 TNM staging 40 Reperfusion 40 ERCS 40 PERSEUS 40 Tumor Registry 40 mITT population 40 INBAR 40 OSIWA 40 Phase Ib Clinical Trial 40 ACUITY trial 40 Western Airborne Contaminants 40 ZyXEL Communications Corporation 40 MEDEX 40 ER CHOP 40 Trial NLST 40 MINUCI 40 Surveillance Epidemiology 40 BioImaging 40 Cervical Cytology 40 Automation Federation www.automationfederation.orgstands athwart 40 Salesian Missions 40 PreDx DRS 40 MEDICAL INC 40 EUROCAE 40 Clinical Antipsychotic Trials 40 Multicenter AIDS 40 REDCOP 40 ug dose 40 HSARPA 40 Galileo Genomics 40 Shigang 40 Minimally Invasive Surgical 40 Garnet Biotherapeutics 40 GRAVITAS trial 40 Ergomed 40 BCR ABL1 40 International Verapamil SR 40 STRATEGY FOR AN OPEN 40 SinoBiomed 40 Endovascular System 40 PHAROS 40 counterpulsation 40 Ellsin 40 COPAXONE R 40 Advanced CANDU Reactor 40 Syndicate c www.project 40 PD2i R 40 ACDU 40 MEDNAX Pediatrix Medical 40 miRview ™ mets 40 Huangyan Island 40 Yageo Corporation 40 CARE HF 40 End Results SEER 40 pegylated interferon alfa 2b 40 Accredits 40 TX TF1 40 Pressure BioSciences 40 CGEMS 40 ACDIS 40 BioRad 40 Vulnerability Assessments 40 HuMax TAC 40 WHO UNAIDS 40 candidate custirsen 40 ENVOY 40 PDNA 40 EMAT 40 Power Infuser 40 HAITI EARTHQUAKE 40 CSF Assurance 40 NTDDS 40 Screening Trial DMIST 40 Cooperation Framework Agreement 40 BUPT 40 Biospheres 40 NYSE TWN 40 Erythropoiesis Stimulating Agents ESAs 40 anthropometric measurements 40 China TravelSky Holding 40 Appropriateness Criteria 40 substudy 40 Kiribati Laos 40 Wanfang 40 ABQAURP 40 CHIA 40 PALOP 40 PIA cad top 40 Acute coronary syndrome 40 Multivariate logistic regression 40 INFRA 40 Atherosclerosis MESA 40 MADIT II 40 Cognitive Aging 40 Hsin Chu Taiwan 40 RESOURCE MANAGEMENT 40 Heart Transplantation 40 UNFPA UNICEF 40 Southeast Anesthesiology Consultants 40 NOD mice 40 KHG 40 AIM HIGH 40 SNCA 40 BioIT 40 IncellDx 40 Coronary artery bypass grafting 40 Institutional Strengthening 40 SAFECOM 40 InfoGard 40 clinicopathologic 40 transrectal ultrasound guided 40 CTAP 40 AtherOx 40 Reg Anesth Pain 40 PHRP 40 YRCS 40 TAIWAN DOLLAR 40 CGDI 40 CGYV 40 Macao SARs 40 ACR accreditation 40 National Chung Hsing 40 null responder HCV 40 MastaScope 40 prospective multicenter study 40 DREF operation 40 TIMP 1 40 Targeted Molecular Diagnostics 40 Neuroepidemiology 40 Interruptible Load 40 HuCAL antibodies 40 AIPR 40 nonrandomized 40 STEEL INDUSTRY 40 rs# [004] 40 OPDS 40 CHINA HOLDINGS 40 ESA ERS 40 NOPR 39 PRAGMA 39 OZURDEX 39 TAXUS IV 39 TSCTP 39 CAPRIE 39 IHST 39 eddy covariance 39 Border Consortium TBBC 39 Hogar de Cristo 39 Cryptographic Modernization 39 phase IIa clinical 39 NATRECOR R 39 ENTERTAINMENT IN BRIEF 39 CONTINUES DOWN 39 ZFP Therapeutics 39 Ortivus 39 IASLC 39 Heart Transplant Recipients 39 PRIALT 39 JASCO 39 Proficiency Testing 39 ADNI 39 BIOPHARMA 39 Preventive Oncology 39 Kouilou potash project 39 PRIMA 39 ISO IEC JTC 39 RAPID RESPONSE 39 AFNOR 39 Agencourt Bioscience 39 UKIERI 39 Medifast NYSE 39 DMID 39 TSEC 39 PRRO 39 Expect flyspeck scrutiny 39 Cardiocore 39 EPSG 39 Multicenter Phase 39 ACTD 39 Bexion 39 Computed Tomographic 39 Tai Fung Bank 39 PSTC 39 CDISC ODM 39 EMPHASIS HF 39 Chemokine 39 Q4B 39 NCS4 39 Hebei Aoxing 39 prospective cohort 39 undergoing Percutaneous Coronary 39 Trichlorosilane TCS 39 CEPP 39 Taiwan ROC 39 thoracoscopic lobectomy 39 ATCI 39 H#N# VACCINE 39 NCAF 39 electrocardiography ECG 39 Nord Trøndelag Health 39 COSPAS SARSAT 39 ULDAGE Inc. 39 FishTail 39 lorcaserin Phase 39 AlCana 39 JPEO JTRS 39 Trandolapril 39 ICBP 39 Nerve Targeting Drug 39 IFN alfa 39 Renal Physicians 39 IABP 39 Nanya Technology Corporation 39 Service Aggregation Router 39 Complete Response CR 39 Timed Walk 39 conducted retrospective cohort 39 CDRD 39 primary percutaneous coronary 39 Xisha Islands 39 randomized controlled trials RCTs 39 Nankang Software Park 39 PDSS 39 MAPT 39 SARSAT 39 UNPF 39 PROCHYMAL 39 QOPI 39 phylogenetic analyzes 39 Aohong 39 Acción Social 39 LRED 39 angiographically 39 MEDIC 39 FGDC 39 neoadjuvant 39 UVIDEM 39 LIFE Biosystems 39 Jaiva Technologies 39 PROC 39 Biophage Pharma 39 SSc 39 STENT 39 Peoples Organization UNPO 39 JAMA. 39 subsidiaries Medicsight PLC 39 CICM 39 Tiaoyutai 39 Geoinformation 39 HYVET 39 MCGHealth Medical 39 Common Toxicity Criteria 39 Teijin Pharma 39 CC genotype 39 Levacor 39 EMEW 39 CDISC standards 39 biostatisticians 39 CBMM 39 ASSAY 39 Recommended Practices 39 RE LY 39 MEDIFAST 39 Arch Pathol Lab 39 Ann Emerg Med 39 BILLING AND 39 Hoang Sa archipelago 39 Kadix Systems 39 CIECA 39 J Immunol 39 QUASAR validation study 39 ACCF 39 Azerspace 39 NDTI 39 Logistic regression 39 AIEF 39 PROPEL trial 39 cobas HPV Test 39 SORT OUT 39 GAMMAGARD 39 patients undergoing percutaneous 39 Veteran Owned 39 MEDMARX 39 BO# 39 Inc. LCV RA 39 USCOM 39 disputed Spratlys 39 Spirus Medical 39 GaozhiSoft 39 PITX2 methylation 39 Bohol Cebu 39 Intervention Effectiveness CATIE 39 TRICOM 39 kilometer 2D seismic 39 Cloretazine 39 iCardiac Technologies 39 idiopathic membranous nephropathy 39 Cardio3KG 39 YCI 39 JR Soc 39 APLAC 39 Shih Hsin University 39 KIF6 carriers 39 WateReuse Foundation 39 Multi Ethnic Study 39 NAIC RBC 39 DermTech International 39 HKPC 39 OFDA 39 Velos eResearch 39 Costa Rica Guatemala Honduras 39 GPEI 39 Huamei 39 Tonga Vanuatu 39 UNDAC 39 thoracic aortic disease 39 Radiology ACR 39 Cheng Kung University 39 BLS ACLS 39 % CI #.#-#.# [005] 39 Pharmacokinetic parameters 39 Outcome Measures 39 ANTI SECESSION LAW 39 antiretroviral naïve 39 Sustainable Communities Strategy 39 Taiyang 39 suppl #S 39 NP2 Enkephalin 39 WebGIS 39 Phylogenetic analyzes 39 multivariate Cox 39 ATRC 39 Ustyurt region 39 cheminformatics techniques 39 Multiethnic Cohort Study 39 UPLYSO 39 Cancer Incidence Mortality 39 OETC 39 Diabetic Foot Ulcer 39 WatSan 39 Innalogic 39 Spratleys 39 ATLIS 39 Min Sheng 39 HHV 6 39 EURIDIS 38 Unrepresented Nations 38 Observational Study 38 CASIC 38 CannaBANK 38 JIPM 38 magnetic radiometric 38 IL#B 38 ERAPSCO joint venture 38 NCT# ClinicalTrials.gov 38 randomized blinded 38 Population Database 38 GreTai Securities Market 38 Prostate Lung Colorectal 38 Guang Dong 38 SMARTworks 38 Celect.org TM 38 MOMENTUM LOOKS TO CONTINUE 38 System BRFSS 38 Cancer Incidence 38 Faraday Plastics 38 GYTS 38 chromosome #q# [002] 38 Anthony Tolcher 38 GERAN 38 ReN# 38 blinded randomized placebo controlled 38 CIME 38 Development Agency USTDA 38 DRN 38 Guides FY# Update 38 Formosat 38 DMLSS 38 HopkinsOne 38 cerebral autoregulation 38 Acute Coronary Syndromes 38 OBJECTIVES 38 liposomal formulation 38 System CIMS 38 inVentiv Clinical 38 AZOR 38 Prognostic Value 38 Stabilization Initiative 38 gene rearrangements 38 Medicsight CAD 38 Cancer Prevention ATBC 38 Walsin Lihwa Corporation 38 www.CHEnergyGroup.com 38 LifeShirt System 38 INTERNATIONAL DEVELOPMENT 38 AFRICAN NATIONS 38 Comorbidity 38 Hypertriglyceridemia 38 IRNSS 38 #p# [003] 38 Framingham Offspring Study 38 Ischemic 38 OTCBB HNAB 38 Meta analyzes 38 Diabetes Complications 38 NEPAD Secretariat 38 Qinnan Block 38 microsimulation model 38 Guoxin 38 Guides FY# Quick Facts 38 MIST Therapy 38 randomized Phase 2b 38 Participatory Rural 38 ePharmaSolutions 38 Virulizin R 38 Biomerk Tumorgrafts 38 HSCT 38 Kwang Yang 38 FMOH 38 I. ORE MAN 38 Finsch diamond mine 38 coronary revascularization 38 COMMIT 38 Affinium Pharmaceuticals 38 Parkinson Foundation PFNCA 38 STRIDE PD 38 Inclinix 38 Cornea Donor Study 38 CIMZIA ™ 38 SEAMEO 38 varespladib 38 ILLEGAL MIGRANTS 38 APTIVUS ritonavir 38 DM3 TM 38 EPOCh 38 DIALYSIS 38 CAMMS# 38 PJTG 38 PD2i 38 Spratly island 38 Ohr Pharmaceutical Inc. 38 adenoviral vectors 38 Zhuhai Municipal 38 TQT 38 Institute LRRI 38 PATRICK CORRIGAN TORONTO 38 Ltd. Joins OTCQX 38 PluriCells 38 Hoang Sa Paracel 38 RECIST criteria 38 Modernization Initiative 38 NITRD 38 SUSTAIN 38 Jinan Military 38 Enzyme Leach 38 Interoperability Experiment 38 JSDF 38 BORSA 38 patientswith 38 genotypic 38 elective percutaneous coronary 38 SGSI 38 J Foot Ankle 38 ESSP 38 CORD II 38 Cethrin 38 Phu Yen Khanh Hoa 38 Proneuron 38 PDV Caribe 38 PTI SJY 38 Focus Humanitarian Assistance 38 Multivariate analysis 38 intra abdominal abscess 38 syngo R 38 Arthroplasty 38 fludarabine cyclophosphamide 38 tolerability pharmacokinetics 38 GAMMON GOLD 38 Healthtrac 38 CNFI 38 Intertek Acquires 38 VVAF 38 FRANKFURT ROC 38 migalastat HCl 38 R4D 38 GSE UNIS 38 Repsol Exploracion 38 Vertebral Fracture 38 TRUS 38 ARCALYST ® rilonacept 38 Xinhai Revolution 38 Nongovernmental 38 Zhao Dong 38 Sublicense Agreement 38 THZ 38 Betou 38 BCDR 38 Retains CCG Investor Relations 38 Business Incubators 38 Interchurch Medical 38 prospectively defined 38 Patient Satisfaction Survey 38 Echocardiographic 38 COU AA 38 Tarceva TM 38 Defibrillation 38 MADIT 38 SafetyNET 38 Acute MI 38 KINROSS GOLD 38 VKORC1 38 HKI 38 Fab #i 38 Centron Telecom 38 GTQ 38 PHX# 38 Etubics 38 Cenduit 38 Taipei Hsien 38 Auria Solar 38 FORCE PROTECTION 38 Azerbaijan Kazakhstan Kyrgyzstan 38 CATIE AD 38 CVZ 38 BS #-#:# 38 Nanjing Jiangsu 38 Etiology 38 EMERGENCY MEDICAL 38 CMSP 38 RBC transfusion 38 AKIP 38 MatchMetrix 38 mg BID dose 38 POSCO ICT 38 BUE 38 APCO P#